Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses
Traumatic spinal cord injury (SCI) is a cause of significant morbidity, often resulting in long-term disability. We aimed to compare outcomes after riluzole versus patients who received placebo or standard of care with no specific intervention. MEDLINE, Embase, Scopus, and Cochrane Library database...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mary Ann Liebert
2024-11-01
|
| Series: | Neurotrauma Reports |
| Subjects: | |
| Online Access: | https://www.liebertpub.com/doi/10.1089/neur.2023.0114 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850275187528826880 |
|---|---|
| author | Luke J. Weisbrod Thomas T. Nilles-Melchert Judith R. Bergjord Daniel L. Surdell |
| author_facet | Luke J. Weisbrod Thomas T. Nilles-Melchert Judith R. Bergjord Daniel L. Surdell |
| author_sort | Luke J. Weisbrod |
| collection | DOAJ |
| description | Traumatic spinal cord injury (SCI) is a cause of significant morbidity, often resulting in long-term disability. We aimed to compare outcomes after riluzole versus patients who received placebo or standard of care with no specific intervention. MEDLINE, Embase, Scopus, and Cochrane Library database searches yielded 92 records, and five met the study inclusion criteria. Fixed-effect and random-effects models were used to establish odds ratios (ORs) and mean difference (MD) with 95% confidence intervals (CIs) for each outcome. The results of the pooled analysis showed that in patients with acute traumatic SCI, riluzole resulted in increased American Spinal Injury Association (ASIA) motor scores at 3 months (MD 0.26, 95% CI [–0.10,0.61], I2 = 0%; p = 0.157) and 6 months (MD 0.21, 95% CI [–0.17,0.60], I2 = 0%; p = 0.280) and change in ASIA Impairment Scale (AIS) at 3 months (OR 0.59, 95% CI [–0.12,1.30], I2 = 0%, p = 0.101) and 6 months (OR 0.28, 95% CI [–0.50,1.06], I2 = 0%, p = 0.479) in comparison to the control groups, though not to a level of statistical significance. Riluzole resulted in fewer adverse events than the control groups (OR −0.12, 95% CI [–1.59,1.35], I2 = 0%, p = 0.874) and lower mortality (OR −0.20, 95% CI [–1.03,0.63], I2 = 0%, p = 0.640), though also not to a level of statistical significance. These meta-analyses suggest that riluzole for the treatment of traumatic SCI is safe and results in improved neurological outcomes when compared to controls, though not to a level of statistical significance. More robust prospective, randomized studies are necessary to help inform the safety and efficacy of riluzole for traumatic SCI. |
| format | Article |
| id | doaj-art-58605ae3abe44cd28ece63e2e7b4f170 |
| institution | OA Journals |
| issn | 2689-288X |
| language | English |
| publishDate | 2024-11-01 |
| publisher | Mary Ann Liebert |
| record_format | Article |
| series | Neurotrauma Reports |
| spelling | doaj-art-58605ae3abe44cd28ece63e2e7b4f1702025-08-20T01:50:52ZengMary Ann LiebertNeurotrauma Reports2689-288X2024-11-015111712710.1089/neur.2023.0114Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-AnalysesLuke J. Weisbrod0Thomas T. Nilles-Melchert1Judith R. Bergjord2Daniel L. Surdell3Department of Neurosurgery, University of Nebraska Medical Center, Omaha, Nebraska, USA.School of Medicine, Creighton University, Omaha, Nebraska, USA.Health Sciences Library, Creighton University, Omaha, Nebraska, USA.Department of Neurosurgery, University of Nebraska Medical Center, Omaha, Nebraska, USA.Traumatic spinal cord injury (SCI) is a cause of significant morbidity, often resulting in long-term disability. We aimed to compare outcomes after riluzole versus patients who received placebo or standard of care with no specific intervention. MEDLINE, Embase, Scopus, and Cochrane Library database searches yielded 92 records, and five met the study inclusion criteria. Fixed-effect and random-effects models were used to establish odds ratios (ORs) and mean difference (MD) with 95% confidence intervals (CIs) for each outcome. The results of the pooled analysis showed that in patients with acute traumatic SCI, riluzole resulted in increased American Spinal Injury Association (ASIA) motor scores at 3 months (MD 0.26, 95% CI [–0.10,0.61], I2 = 0%; p = 0.157) and 6 months (MD 0.21, 95% CI [–0.17,0.60], I2 = 0%; p = 0.280) and change in ASIA Impairment Scale (AIS) at 3 months (OR 0.59, 95% CI [–0.12,1.30], I2 = 0%, p = 0.101) and 6 months (OR 0.28, 95% CI [–0.50,1.06], I2 = 0%, p = 0.479) in comparison to the control groups, though not to a level of statistical significance. Riluzole resulted in fewer adverse events than the control groups (OR −0.12, 95% CI [–1.59,1.35], I2 = 0%, p = 0.874) and lower mortality (OR −0.20, 95% CI [–1.03,0.63], I2 = 0%, p = 0.640), though also not to a level of statistical significance. These meta-analyses suggest that riluzole for the treatment of traumatic SCI is safe and results in improved neurological outcomes when compared to controls, though not to a level of statistical significance. More robust prospective, randomized studies are necessary to help inform the safety and efficacy of riluzole for traumatic SCI.https://www.liebertpub.com/doi/10.1089/neur.2023.0114riluzolespinal cord injurytrauma |
| spellingShingle | Luke J. Weisbrod Thomas T. Nilles-Melchert Judith R. Bergjord Daniel L. Surdell Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses Neurotrauma Reports riluzole spinal cord injury trauma |
| title | Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses |
| title_full | Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses |
| title_fullStr | Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses |
| title_full_unstemmed | Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses |
| title_short | Safety and Efficacy of Riluzole in Traumatic Spinal Cord Injury: A Systematic Review With Meta-Analyses |
| title_sort | safety and efficacy of riluzole in traumatic spinal cord injury a systematic review with meta analyses |
| topic | riluzole spinal cord injury trauma |
| url | https://www.liebertpub.com/doi/10.1089/neur.2023.0114 |
| work_keys_str_mv | AT lukejweisbrod safetyandefficacyofriluzoleintraumaticspinalcordinjuryasystematicreviewwithmetaanalyses AT thomastnillesmelchert safetyandefficacyofriluzoleintraumaticspinalcordinjuryasystematicreviewwithmetaanalyses AT judithrbergjord safetyandefficacyofriluzoleintraumaticspinalcordinjuryasystematicreviewwithmetaanalyses AT daniellsurdell safetyandefficacyofriluzoleintraumaticspinalcordinjuryasystematicreviewwithmetaanalyses |